维普中文期刊产品整合服务
38篇 您的检索式:作者名="Mutnick AH"
    题名 作者 年代 出处 被引量
1Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America ( 1999-2001 ) 显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
2Antimierobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
3Antimicrobial usage and resistance trend relationships from the MYSTIC programme in North America(1999-2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
4Antimicrobial activity of LB10827,a new orally administered cephalosporin,tested against Haemophilus influenzae,Moraxella catarrhalis and Streptococcus pneumoniae显示文摘Deshpande LM Beach ML Mutnick AH 2003Clin Microbiol Infect2003,9,8:1
5Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program(2000)显示文摘Kirby JT Mutnick AH Jones RN 2002Diagn Microbiol Infect Dis2002,439,4:1
6Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimierobial Surveillance Program (2000) 显示文摘Kirby JT Mutnick AH Jones RN 2002Diagn Microbiol Infect Dis2002,439,4:1
7Linezolid resistance since 2001: Sentry antimicrobial surveillance program 显示文摘Mutnick AH Enne V Jones RN 2003Ann Pharmacother2003,37,6:1
8In vitro evaluation of BAL9141,a novel parenteral cephalosporin active against oxacillin-resistant staphylococci显示文摘JONES RN DESHPANDE LM MUTNICK AH 2002J Antimicrob Chemother2002,50,6:1
9Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000)显示文摘 Mutnick AH Jones RN 2002Diagn Microbiol Infect Dis2002,43,4:1
10Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999 - 2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
11Antimicrobial usage and resistancetrend relationships from the MYSTIC Programme in North America(1999-2001)显示文摘Mutnick AH Rhomberg PR 0,,02:1
12Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in north america:results of the in hospitalized patients in north america:results of the SENTRY antimicrobial surveillance study 2000显示文摘Hoban DJ Biedenbach DJ Mutnick AH 2003Diagn Microbiol Infect Dis2003,45,27:1
13Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program显示文摘Mutnick AH Enne V Jones RN 2003Ann Pharmacother2003,37,6:1
14Emerging antimicrobial resistances among Proteus mirabilis in Europe显示文摘Mutnick AH Turner PJ Jones RN 2002J Chemothera2002,14,3:1
15Antimicrobial usage and resistance trend relationships from the MYSTIC programme in North America(1999 -- 2001) 显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
16Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America(1999- 2001) 显示文摘Mutnick AH Rhomberg PR Sader HS 2004Antimicrob Chemother2004,53,2:1
17Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America(1999~2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
18Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999 ~ 2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
19Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
20Pathogen of occur- rence and susceptibility patterns associated with pneumonia in hos- pitalized patients in North America: results of the SENTRY Anti- microbial Surveillance Study (2000) 显示文摘Hoban DJ Biedenbaeh DJ Mutnick AH 2003Diagnostic microbiology and infectious disease2003,45,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费